Lupus Research Alliance logo
Lupus Research Alliance

LRA-Genentech Award on Immune Resetting Therapies for Lupus

Helps yr for pilot or mechanistic immune resetting research in lupus co-funded through the LRAGenentech Award on Immune Resetting Therapies for.

Between cyclesLupus Research AllianceUnited States

The LRA-Genentech Award on Immune Resetting Therapies for Lupus is a co-funded grant program supported by the Lupus Research Alliance (LRA) and Genentech, a leading biopharmaceutical company. The LRA, a New York 501(c)(3) (Federal Tax ID #58-2492929) with over $284 million distributed across 675+ grants, identified immune resetting as a core strategic priority in its 2024–2028 Research Roadmap, wh…

Immune resetting therapies for lupus: one-year pilot projects on novel immune resetting technologies or methodologies, or two-year mechanistic research into current or emerging immune resetting therapies, co-funded with Genentech.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Annual
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.12–24 months
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see the timeline

Guides for this application

All guides →
National Institutes of Health logo
Scheduled

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research

NIH · United States

Funds further development and rigorous technical validation of a cancer research technology that has already cleared basic feasibility.

BiotechMedtech+1
$300KJun'27
Cystic Fibrosis Foundation logo
Open

CFF Clinical Research Award

🇺🇸CFF · United States

Supports investigator-driven clinical studies addressing diagnosis, treatment, and prevention across key medical priorities.

MedtechBiotech
$150K – $350K
National Institutes of Health logo
Open

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research

🇺🇸NIH · United States

Funds rigorously validating a transformative, multi-use platform or technology aimed at heart, lung, blood or sleep disease.

BiotechMedtech
$350KDec'27
National Institutes of Health logo
Open

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy

🇺🇸NIH · United States

Funds work combining imaging with liquid biopsy during cancer treatment, to see sooner whether it is working or resistance is emerging.

MedtechBiotech
$500KJan'28
National Institutes of Health logo
Open

Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions

🇺🇸NIH · United States

Funds small clinical-trial research at undergraduate-focused colleges that get under $6 million a year from NIH.

BiotechMedtech
$375KJan'27
National Institutes of Health logo
Open

NIDCD Research Grants for Translating Basic Research into Clinical Practice

NIH · United States

Funds translational research turning basic findings into clinical tools for communication disorders, with practical clinical impact required.

BiotechMedtech
$500KOct'27